Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.
about
G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?Predictive value of epigenetic alterations in head and neck squamous cell carcinomaAberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinomaTruncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stageGalanin has tumor suppressor activity and is frequently inactivated by aberrant promoter methylation in head and neck cancerPrognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.Epigenetic control of cancer by neuropeptides.Regulation of DNA methylation on EEF1D and RPL8 expression in cattle.Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis.Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis.Association of TET3 epigenetic inactivation with head and neck cancer.The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis.
P2860
Q26801162-C6B9FA5B-C3C7-44F1-A02C-FBFCDD4D7C69Q27690755-C2AF60B7-4A03-4336-B210-0938513E36B3Q35143989-44051717-065D-4228-B838-6465662C6126Q36502347-C3694C9C-1429-4B8E-B0F5-D4A78CF9BEAEQ36865069-B01DE7BD-9E28-4385-8E51-7555CDAF679AQ37295588-ECAC0F5D-22BA-4796-BACF-789410993DF2Q38484647-B3D1CDE0-75FE-4027-90A0-B9914EEBE0F2Q38998556-B617C0CD-4B59-4E4A-96D6-2C090C8C2AB7Q41669845-765A0F8A-5288-4D60-844B-1650F9A1D445Q45501420-32FFFDFD-AD90-4FE7-8DA8-6D7F242EA239Q47961085-10B62CE3-5BBE-463D-A270-BD4B0A7E7177Q48182545-3AF1FCE1-C1EB-4AD2-A95E-5117A8C7E63AQ55280456-5EB964E1-E61F-4316-A6D7-E6D64F909487Q55346706-B2289AEA-97DA-4AC3-B0F5-481A9C2FE6AD
P2860
Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@en
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@nl
type
label
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@en
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@nl
prefLabel
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@en
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@nl
P2093
P2860
P1476
Frequent promoter hypermethyla ...... rker for head and neck cancer.
@en
P2093
Atsushi Imai
Daiki Mochizuki
Goro Takahashi
Hiroyuki Mineta
Kiyoshi Misawa
Shiori Endo
Takayuki Uehara
Takeharu Kanazawa
Yuki Misawa
P2860
P2888
P304
P356
10.1007/S00432-013-1393-5
P577
2013-02-19T00:00:00Z